HB1057 is a broad rewrite of Missouri law governing infectious and communicable diseases, with the bill text showing a major shift away from HIV-specific provisions toward the broader category of “serious infectious or communicable disease.” It repeals or replaces numerous sections across the health, criminal, insurance, real estate, pharmacy, and court codes, and updates terminology throughout to reflect current medically recommended screening and infection-control practices. The bill also adds new or revised provisions for testing, confidentiality, reporting, and professional practice standards.
Among its most significant changes, the bill expands court-ordered testing and victim-notification provisions in sexual offense and related cases, requires certain defendants to undergo testing before incarceration, and allows victims access to results in specified circumstances. It also directs the Department of Health and Senior Services to pay for testing for victims of rape, sodomy, and incest, and to use public health laboratory testing. In the healthcare setting, the bill updates universal precautions, training, and evaluation standards for professionals performing invasive procedures, and it preserves the department’s authority to intervene where a practitioner poses a grave and unjustifiable risk.
The bill also revises pharmacy law to expressly authorize pharmacists to dispense HIV pre-exposure and post-exposure prophylaxis under physician protocols, and it updates insurance and real estate provisions by removing HIV-specific references from definitions and disclosure rules. In criminal law, it removes the prior felony enhancement for prostitution based on HIV status and replaces it with a more general treatment-oriented framework. Other sections update confidentiality rules for court records and deceased-patient notifications, and replace older HIV-only language with broader disease-related terminology.
Because there were no committee transcripts or recorded votes provided, the general sentiment cannot be measured from debate or roll-call history. Based on the bill’s structure, it appears to be a modernization and consolidation measure rather than a narrowly punitive one, with a strong public-health and administrative focus. The repeated replacement of HIV-specific language with broader infectious-disease language suggests an intent to align statutes with current medical guidance and to standardize procedures across agencies and professions.
The main points of contention likely center on expanded testing authority, confidentiality, and disclosure requirements, especially in criminal cases and healthcare settings. Potentially affected parties include defendants in sexual offense and prostitution cases, victims seeking test results, healthcare professionals subject to practice restrictions, insurers, pharmacists, healthcare facilities, and the Department of Health and Senior Services. The bill’s broad reach across multiple chapters means it could raise concerns about privacy, due process, stigma, and the scope of mandatory or court-ordered disease testing.
HB1057 would repeal or amend a large set of Missouri statutes and replace HIV-specific provisions with broader references to serious infectious or communicable diseases in many contexts. It would affect public health testing authority, confidentiality rules, criminal procedure, healthcare professional regulation, pharmacy practice, insurance definitions, real estate disclosure rules, and victim-notification provisions. The bill also creates or revises sections governing pharmacist authority to dispense HIV PrEP and PEP, and it updates infection-control and reporting requirements for healthcare facilities and professionals.
No committee transcripts or votes were provided, so there is no recorded legislative debate or roll-call sentiment to summarize. From the bill text alone, the measure appears generally policy-driven and technical, aimed at updating older HIV-specific statutes and broadening them to current communicable-disease terminology. The overall tone is administrative and public-health oriented, though it includes several provisions that could be viewed as more enforcement-focused in criminal and disclosure contexts.
Likely areas of contention include mandatory or court-ordered testing, disclosure of test results to victims and law enforcement, and the balance between public health and privacy/confidentiality. Healthcare professionals and facilities may be concerned about expanded training, evaluation, and practice-restriction standards, while criminal defendants and civil-liberties advocates may object to testing without refusal rights and broader information sharing. Insurers, pharmacists, and real estate professionals are also affected by statutory cleanup and scope changes, though those changes appear less controversial than the criminal-justice and confidentiality provisions.